Implantable Cardioverter Defibrillators: Do Women Fare Worse Than Men? Gender Comparison in the INTRINSIC RV Trial
- 26 August 2009
- journal article
- research article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 20 (9), 973-978
- https://doi.org/10.1111/j.1540-8167.2009.01489.x
Abstract
Due to limited enrollment of women in previous trials, there is a paucity of data comparing outcome and arrhythmic events in men versus women with implantable cardioverter defibrillators (ICDs). We analyzed outcome of patients in the INTRINSIC RV (Inhibition of Unnecessary RV Pacing with AV Search Hysteresis in ICDs) trial based on gender. Women comprised 19% (293/1530) of the INTRINSIC RV population. Compared with men, women were less likely to have coronary disease, ischemic cardiomyopathy, and hyperlipidemia, and were more likely to have congestive heart failure and diabetes. Women were less likely to receive beta blockers and ACE inhibitors, and more likely to receive diuretics. Over 10.8 +/- 3.5 months of follow-up, unadjusted mortality was higher in women than men (6.8% vs 4.1%, P = 0.04). Heart failure hospitalizations occurred in 7.9% of women versus 5.7% of men (P = 0.13). After adjustment for baseline differences and drug therapy, there was no significant difference in mortality between men and women. Adverse events were observed more often in women. There were no gender differences in the percentage of patients receiving appropriate or inappropriate ICD shocks. In INTRINSIC RV, women receiving ICDs differed from men regarding baseline characteristics and drug therapy. After adjusting for baseline differences and medical therapy, there were no differences in heart failure hospitalization, survival, or ICD shock therapy during follow-up. Apparent undertreatment of heart failure and greater frequency of adverse advents in women receiving ICDs warrant further investigation.Keywords
This publication has 34 references indexed in Scilit:
- Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathyAmerican Heart Journal, 2008
- Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure TrialJournal of Cardiovascular Electrophysiology, 2008
- Influence of gender on ICD implantation for primary and secondary prevention of sudden cardiac deathEP Europace, 2006
- Factors Influencing Appropriate Firing of the Implanted Defibrillator for Ventricular Tachycardia/Fibrillation: Findings From the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II)Journal of the American College of Cardiology, 2005
- Influence of Gender on Arrhythmia Characteristics and Outcome in the Multicenter UnSustained Tachycardia TrialJournal of Cardiovascular Electrophysiology, 2004
- Trends in Heart Failure Incidence and Survival in a Community-Based PopulationJama-Journal Of The American Medical Association, 2004
- Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection FractionThe New England Journal of Medicine, 2002
- Gender differences in device therapy for malignant ventricular arrhythmiasArchives of Internal Medicine, 1995
- Clinical predictors of implantable cardioverter-defibrillator shocks (results of the CASCADE trial)The American Journal of Cardiology, 1994
- Prognostic significance of arrhythmia inducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrestThe American Journal of Cardiology, 1988